PUBLISHER: IMARC | PRODUCT CODE: 1520556
PUBLISHER: IMARC | PRODUCT CODE: 1520556
North America Travel Vaccines Market Report by Composition, Disease, and Country 2024-2032
The North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on composition and disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Composition
Mono Vaccines
Combination Vaccines
Market by Disease
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report
- 1. What was the size of the North America travel vaccines market in 2023?
- 2. What is the expected growth rate of the North America travel vaccines market during 2024-2032?
- 3. What are the key factors driving the North America travel vaccines market?
- 4. What has been the impact of COVID-19 on the North America travel vaccines market?
- 5. What is the breakup of the North America travel vaccines market based on the composition?
- 6. What is the breakup of the North America travel vaccines market based on the disease?
- 7. What are the key regions in the North America travel vaccines market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Travel Vaccines Market
- 5.1 Market Performance
- 5.2 Market Breakup by Composition
- 5.3 Market Breakup by Disease
- 5.4 Market Breakup by Region
- 5.5 Market Forecast
6 North America Travel Vaccines Market
- 6.1 Market Performance
- 6.2 Impact of COVID-19
- 6.3 Market Forecast
7 North America Travel Vaccines Market: Breakup by Composition
- 7.1 Mono Vaccines
- 7.2 Combination Vaccines
8 North America Travel Vaccines Market: Breakup by Disease
- 8.1 Hepatitis A
- 8.2 DPT
- 8.3 Yellow Fever
- 8.4 Typhoid
- 8.5 Hepatitis B
- 8.6 Measles and Mumps
- 8.7 Rabies
- 8.8 Meningococcal
- 8.9 Varicella
- 8.10 Japanese Encephalitis
- 8.11 Others
9 North America Travel Vaccines Market: Breakup by Country
- 9.1 United States
- 9.1.1 Historical Market Trends
- 9.1.2 Market Breakup by Composition
- 9.1.3 Market Breakup by Disease
- 9.1.4 Market Forecast
- 9.2 Canada
- 9.2.1 Historical Market Trends
- 9.2.2 Market Breakup by Composition
- 9.2.3 Market Breakup by Disease
- 9.2.4 Market Forecast
- 9.3 Mexico
- 9.3.1 Historical Market Trends
- 9.3.2 Market Breakup by Composition
- 9.3.3 Market Breakup by Disease
- 9.3.4 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
- 11.1 Overview
- 11.2 Exploratory Stage
- 11.3 Preclinical and Clinical Development
- 11.4 Regulatory Approval
- 11.5 Manufacturing
- 11.6 Marketing and Distribution
12 Porter's Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Rivalry
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
List of Figures
- Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2018-2023
- Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2023
- Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2023
- Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2023
- Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2024-2032
- Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2018-2023
- Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2024-2032
- Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2023
- Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2023
- Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million US$), 2018 & 2023
- Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2023
- Figure 38: United States: Travel Vaccines Market: Value Trends (in Million US$), 2018-2023
- Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2023
- Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2023
- Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2018-2023
- Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2023
- Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2023
- Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2018-2023
- Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2023
- Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2023
- Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2024-2032
- Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
- Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
- Figure 52: North America: Travel Vaccines Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2023 and 2032
- Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2024-2032
- Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2024-2032
- Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2024-2032
- Table 5: North America: Travel Vaccines Market: Competitive Structure
- Table 6: North America: Travel Vaccines Market: Key Players
